Exponent Inc(EXPO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 30.23 | EPS (ttm) | 2.23 | Insider Own | 1.2% | Shs Outstand | 47.5M | Perf Week | -3.86% |
| Market Cap | 3.20B | Forward P/E | 25.59 | EPS next Y | 14.12% | Insider Trans | -4.72% | Shs Float | 47.0M | Perf Month | -1.49% |
| Enterprise Value | 3.22B | PEG | 2.24 | EPS next Q | 0.6 | Inst Own | 98.81% | Short Float | 6.37% | Perf Quarter | 21.6% |
| Income | 0.11B | P/S | 5.06 | EPS this Y | 11.38% | Inst Trans | -2.82% | Short Ratio | 5.8 | Perf Half Y | -3.86% |
| Sales | 0.63B | P/B | 11.09 | EPS next 5Y | 11.4% | ROA | 15.83% | Short Interest | 2.99M | Perf YTD | -3.07% |
| Book/sh | 6.07 | P/C | 48.05 | EPS past 3/5Y | 1.86% 5.97% | ROE | 31.2% | 52W High | -17.84% ($81.95) | Perf Year | -2.95% |
| Cash/sh | 1.4 | P/FCF | 29.49 | Sales past 3/5Y | 4.28% 7.79% | ROIC | 30.83% | 52W Low | 29.71% ($51.91) | Perf 3Y | -23.75% |
| Dividend Est. | $1.24 (1.84%) | EV/EBITDA | 23.33 | EPS Y/Y TTM | 11.59% | Gross Margin | 24.6% | Volatility(W/M) | 2.42% 2.61% | Perf 5Y | -41.31% |
| Dividend TTM | 1.23 | EV/Sales | 5.08 | Sales Y/Y TTM | 12.84% | Oper. Margin | 20.17% | ATR (14) | 1.87 | Perf 10Y | 173.25% |
| Dividend Ex-Date | 2026/9/4 | Quick Ratio | 1.98 | EPS Q/Q | 16.39% | Profit Margin | 17.67% | RSI (14) | 45.66 | Recom | 1.6 |
| Dividend Gr. 3/5Y | 7.72% 9.57% | Current Ratio | 1.98 | Sales Q/Q | 20.89% | SMA20 | -2.76% ($69.24) | Beta | 0.7 | Target Price | $84 |
| Payout | 58.01% | Debt/Eq | 0.28 | Earnings | 2026/7/30 | SMA50 | 2.04% ($65.98) | Rel Volume | 0.51 | Prev Close | $67.47 |
| Employees | 1212 | LT Debt/Eq | 0.26 | EPS/Sales Surpr. | 9.21% 2.67% | SMA200 | 0.54% ($66.97) | Avg Volume(3M) | 0.52M | Price | $67.33 |
| IPO | 1990/8/17 | Option/Short | Yes/Yes | Trades | 6210 | Volume | 263,829 | Change | -0.21% |
Company
EXPO is a Industrials sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 A U.S. consulting company that provides engineering and scientific consulting services. It offers specialized engineering and scientific consulting such as accident and failure cause analysis, product safety, and litigation support, and is characterized by high margins and a professional workforce. The company operates in the engineering and scientific consulting sector.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
EXPO makes money exceptionally well
20.17% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.4% this year.
Tap to view numbers
The price looks about right
Trading at 30.2 times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -23.8% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.84% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 98.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $3B.
FAQ
What kind of company is EXPO?
EXPO belongs to the Industrials sector and operates in the Engineering & Construction industry.
What is the market cap of EXPO?
The market cap of EXPO is approximately $3.2B, ranking 1,734 within its sector.
Does EXPO pay dividends?
EXPO has a dividend yield of approximately 1.84%, with an annual dividend of $1.24.
What is the P/E ratio of EXPO?
EXPO has a P/E ratio of approximately 30.2x, which can be used to assess its valuation relative to the Industrials sector average.
What is the 52-week high and low for EXPO?
EXPO has recorded a 52-week high of $81.95 and a low of $51.91.